An open observational safety study during administration of Topamac [topiramate], as monotherapy in epileptic patients with no prior treatment or unsuccessfully treated with other antiepileptic drug

Trial Profile

An open observational safety study during administration of Topamac [topiramate], as monotherapy in epileptic patients with no prior treatment or unsuccessfully treated with other antiepileptic drug

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Topiramate (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 13 Oct 2009 Actual patient number (80) added as reported by ClinicalTrials.gov.
    • 20 Mar 2008 Status changed from in progress to completed based on information from the ClinicalTrials.gov site.
    • 30 Jul 2007 Status changed from initiated to in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top